| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |